CATALYST PHARMACEUTICALS INC. - COMMON STOCK
21.48
22-11月-24 16:44:58
15 分の遅延
株式
+0.36
+1.70%
本日の幅
21.05 - 21.55
ISIN
N/A
ソース
NASDAQ
-
Catalyst Pharmaceuticals to Launch LEMS Aware Podcast on Rare Disease Day 2022
17 2 2022 08:03:00 提供 Nasdaq GlobeNewswire
-
07 2 2022 08:03:00 提供 Nasdaq GlobeNewswire
-
03 2 2022 08:03:00 提供 Nasdaq GlobeNewswire
-
10 1 2022 08:03:00 提供 Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Participate in January 2022 Virtual Investor Conferences
04 1 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
06 12 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
15 11 2021 16:15:00 提供 Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Reports Third Quarter 2021 Financial Results
09 11 2021 16:15:04 提供 Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 9, 2021
25 10 2021 08:03:00 提供 Nasdaq GlobeNewswire
-
30 9 2021 12:08:12 提供 Nasdaq GlobeNewswire
-
17 9 2021 08:03:00 提供 Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
10 9 2021 08:03:00 提供 Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Appoints Mary Coleman as Vice President, Head of Investor Relations
16 8 2021 08:03:00 提供 Nasdaq GlobeNewswire
-
09 8 2021 16:39:16 提供 Nasdaq GlobeNewswire
-
26 7 2021 08:03:00 提供 Nasdaq GlobeNewswire
-
19 7 2021 08:03:00 提供 Nasdaq GlobeNewswire
-
06 7 2021 08:03:00 提供 Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Appoints Pharmaceutical Executive Molly Harper to its Board of Directors
29 6 2021 08:03:00 提供 Nasdaq GlobeNewswire
-
28 6 2021 16:30:00 提供 Nasdaq GlobeNewswire